Early Phase Cancer Research in the COVID-19 Pandemic: an ECMC North Initiative

Keith, N. , Plummer, R., Coyle, V., Cameron, D., Evans, J. , Twelves, C., Palmer, D., Danson, S., Graham, D. and Welisch, G. (2021) Early Phase Cancer Research in the COVID-19 Pandemic: an ECMC North Initiative. Project Report. OSF. (doi:10.17605/OSF.IO/6WTN2).

Full text not currently available from Enlighten.

Publisher's URL: https://doi.org/10.17605/OSF.IO/6WTN2

Abstract

The COVID-19 pandemic has brought into focus the complexity and interrelatedness of the range of health care delivery associated with translational cancer research. Importantly it highlights the potential fragility and also strengths of this ecosystem.

Item Type:Research Reports or Papers (Project Report)
Keywords:Adaptation, barriers and fears, clinical trials, Covid and cancer, Covid testing, dataset, digital tools, ethics, global perspective, human impact, impact on research, industry, mortality, networking, opportunities, patient experience, patient recruitment, regulation, remote care, resilience, systemic impact, training.
Status:Published
Glasgow Author(s) Enlighten ID:Keith, Professor Nicol and Evans, Professor Jeff and Welisch, Mr Gaston
Authors: Keith, N., Plummer, R., Coyle, V., Cameron, D., Evans, J., Twelves, C., Palmer, D., Danson, S., Graham, D., and Welisch, G.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Publisher:OSF
Published Online:05 January 2021

University Staff: Request a correction | Enlighten Editors: Update this record